study

Study Finds ELISAs in Milk Samples Less Reliable for Johne’s Disease Detection — $198M in Dairy Losses Underscore Need for More Accurate Milk Testing

Peer-reviewed (in-press) study finds serum-based antibody tests align, but milk results vary—calling for improved milk-specific diagnostics to strengthen herd surveillance…

2 months ago

BML Munjal University to host Leadership Summit on Youth Entrepreneurship and Start-up Governance

NEW DELHI, Oct. 29, 2025 /PRNewswire/ -- BML Munjal University (BMU), a Hero Group initiative, will host the 6th edition…

2 months ago

Two-thirds of surveyed enterprises in EMEA report significant productivity gains from AI, finds new IBM study

66% of responding senior leaders say AI has already driven significant productivity improvements across their organization 41% of respondents anticipate…

2 months ago

Updated IOC report shows 86 per cent of all permanent Olympic venues still in use

23 October 2025 - An updated analysis of venues shows that 86 per cent of all permanent venues used at the…

3 months ago

Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer

Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients1 New findings from this investigational…

3 months ago

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer

Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase 1/2 RAINFOL™-01 trial showed rinatabart sesutecan (Rina-S®) 100…

3 months ago

Sinocare Showcases Its Comprehensive Diabetes Management Solutions at EASD

VIENNA, Oct. 15, 2025 /PRNewswire/ -- The 61st Annual Meeting of the European Association for the Study of Diabetes (EASD…

3 months ago

NEW RESEARCH: Kemira Water Index 2025 exposes critical weaknesses in water resilience and alarming consumer unpreparedness

New international study led by Kemira identifies where people are most vulnerable if their community suddenly loses access to clean…

3 months ago

HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress

The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal cell carcinoma patients after progression on first-line therapies…

3 months ago

Berlin Heals Holding AG Successfully Completes Enrollment in Phase I of the CMIC-III Less Invasive Study

Completed Enrollment in First-In-Human Phase I study of Less Invasive Approach Expected to Present 6-Month data in 2026 at a…

3 months ago